Last reviewed · How we verify
DEXIBUPROFEN
At a glance
| Generic name | DEXIBUPROFEN |
|---|---|
| Drug class | dexibuprofen |
| Target | Prostaglandin G/H synthase 1 |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
| First approval | 1994 |
Approved indications
- Dysmenorrhea
- Fever
- Headache disorder
- Juvenile rheumatoid arthritis
- Osteoarthritis
- Pain
- Rheumatoid arthritis
Common side effects
Key clinical trials
- Phase I Study to Evaluate the Safety of Dexibuprofen 200mg Under Fasting and Fed Conditions (PHASE1)
- Phase I Study to Evaluate the Safety of Dexibuprofen 300mg Under Fasting and Fed Conditions (PHASE1)
- The Effect on Knee Joint Loads of Analgesic Use Compared With Exercise in Patients With Knee Osteoarthritis - An RCT (NA)
- Dexibuprofen 400 mg Sachet Versus Ibuprofen 400 mg Sachet in Patients With Osteoarthritis of the Hip or Knee (PHASE4)
- The Efficacy and Safety of Dexibuprofen Syrup (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |